Company research / RENEF
Cartesian Growth Corp II (RENEF)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.
Annual financials
| Period ended | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2021-10-12 |
|---|---|---|---|---|---|---|
| Operating Income | -$931.5K | -$1.04M | -$2.03M | -$685.1K | — | — |
| Net Income | -$1.51M | $8.21M | $11.44M | $4.93M | — | — |
| EPS (Diluted) | — | — | — | $0.24 | — | — |
| Total Assets | $38.28M | $85.00M | $174.58M | $240.60M | $463.6K | — |
| Total Liabilities | $26.71M | $20.70M | $18.87M | $18.89M | $442.4K | — |
| Shareholders' Equity | -$26.34M | -$20.26M | -$18.54M | -$18.04M | $21.3K | $0 |
| Operating Cash Flow | -$773.8K | -$814.2K | -$922.7K | -$842.9K | — | — |
| Weighted Average Diluted Shares | — | — | — | 5.75M | — | — |
| EPS (Basic) | — | — | — | $0.24 | — | — |